Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02530944 · ClinicalTrials.gov registry record
Web-based Genetic Research on Lupus
A clinical trial of Systemic Lupus Erythematosus, sponsored by 23andMe.
- Completed
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT02530944 is a study of Systemic Lupus Erythematosus that has completed, run by 23andMe. The registered enrollment target is 5,000 participants, above the 330-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (1415% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02530944, a study of Systemic Lupus Erythematosus, has completed, sponsored by 23andMe.
- COMPLETED
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.
Conditions Studied
Study Locations (1)
California
- Www.23Andme.Com/Lupus - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02530944
The ClinicalTrials.gov registry entry for NCT02530944 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 330-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (1415% higher). The listed sponsor is 23andMe, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 0 interventions.
NCT02530944 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02530944 about?
NCT02530944 is a clinical study titled "Web-based Genetic Research on Lupus". The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.
What is the current status of trial NCT02530944?
This trial is currently completed. The enrollment target is 5,000 participants. The study started on 2015-05. Estimated completion is 2017-10-31.
What conditions does trial NCT02530944 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus.
Who is sponsoring clinical trial NCT02530944?
This trial is sponsored by 23andMe, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02530944 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
RECRUITING · Phase 3
-
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
RECRUITING · Phase 1
-
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
RECRUITING
-
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.